{"id":38472,"date":"2026-05-19T14:59:48","date_gmt":"2026-05-19T12:59:48","guid":{"rendered":"https:\/\/mabdesign.fr\/?p=38472"},"modified":"2026-05-19T15:00:41","modified_gmt":"2026-05-19T13:00:41","slug":"myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/","title":{"rendered":"Myonex triple ses capacit\u00e9s de conditionnement primaire de produits hautement actifs et cytotoxiques en France"},"content":{"rendered":"\n<p><\/p>\n\n\n\n<p>Myonex annonce l\u2019extension de ses capacit\u00e9s de conditionnement primaire avec l\u2019autorisation de r\u00e9aliser sur son site du Haillan, en France, des op\u00e9rations de conditionnement primaire sous BPF (Bonnes Pratiques de Fabrication) pour des produits pharmaceutiques hautement actifs et dangereux, incluant des compos\u00e9s cytotoxiques et hormonaux. <\/p>\n\n\n\n<p>\u00c0 mesure que les pipelines cliniques et les portefeuilles commerciaux s\u2019\u00e9largissent pour int\u00e9grer une gamme croissante de chimioth\u00e9rapies, traitements immunosuppresseurs, th\u00e9rapies cibl\u00e9es et traitements hormonaux, le besoin de capacit\u00e9s de conditionnement primaire capables de r\u00e9pondre \u00e0 des exigences strictes de manipulation et de confinement augmente, sans compromis sur la fiabilit\u00e9 de l\u2019ex\u00e9cution ni sur le respect des d\u00e9lais. <\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>\ud83d\udc49 Lire le communiqu\u00e9 de presse ici :<br><a href=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Myonex_Press_Release_May26_FR.pdf\">http:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Myonex_Press_Release_May26_FR.pdf<\/a><\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img fetchpriority=\"high\" decoding=\"async\" width=\"965\" height=\"699\" src=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Highly_Potent_Blistering.jpg\" alt=\"\" class=\"wp-image-38464\" style=\"width:510px;height:auto\" srcset=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Highly_Potent_Blistering.jpg 965w, https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Highly_Potent_Blistering-300x217.jpg 300w, https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Highly_Potent_Blistering-768x556.jpg 768w\" sizes=\"(max-width: 965px) 100vw, 965px\" \/><\/figure>\n\n\n\n<p><br><a href=\"https:\/\/synthelis.com\/communiques-de-presse\/\">To know more<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Myonex annonce l\u2019extension de ses capacit\u00e9s de conditionnement primaire avec l\u2019autorisation de r\u00e9aliser sur son site du Haillan, en France, des op\u00e9rations de conditionnement primaire sous BPF (Bonnes Pratiques de Fabrication) pour des produits pharmaceutiques hautement actifs et dangereux, incluant des compos\u00e9s cytotoxiques et hormonaux.<\/p>\n","protected":false},"author":6,"featured_media":38469,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36,32,18],"tags":[],"class_list":["post-38472","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-our-members","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Myonex triple ses capacit\u00e9s de conditionnement primaire de produits hautement actifs et cytotoxiques en France - MabDesign<\/title>\n<meta name=\"description\" content=\"Myonex annonce l\u2019extension de ses capacit\u00e9s de conditionnement primaire avec l\u2019autorisation de r\u00e9aliser sur son site du Haillan, en France, des op\u00e9rations de conditionnement primaire sous BPF (Bonnes Pratiques de Fabrication) pour des produits pharmaceutiques hautement actifs et dangereux, incluant des compos\u00e9s cytotoxiques et hormonaux.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myonex triple ses capacit\u00e9s de conditionnement primaire de produits hautement actifs et cytotoxiques en France - MabDesign\" \/>\n<meta property=\"og:description\" content=\"Myonex annonce l\u2019extension de ses capacit\u00e9s de conditionnement primaire avec l\u2019autorisation de r\u00e9aliser sur son site du Haillan, en France, des op\u00e9rations de conditionnement primaire sous BPF (Bonnes Pratiques de Fabrication) pour des produits pharmaceutiques hautement actifs et dangereux, incluant des compos\u00e9s cytotoxiques et hormonaux.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-19T12:59:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-19T13:00:41+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Myonex-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Maissa Pote\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maissa Pote\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/\"},\"author\":{\"name\":\"Maissa Pote\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029\"},\"headline\":\"Myonex triple ses capacit\u00e9s de conditionnement primaire de produits hautement actifs et cytotoxiques en France\",\"datePublished\":\"2026-05-19T12:59:48+00:00\",\"dateModified\":\"2026-05-19T13:00:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/\"},\"wordCount\":153,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Myonex-logo.jpg\",\"articleSection\":[\"News\",\"Our members\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/\",\"name\":\"Myonex triple ses capacit\u00e9s de conditionnement primaire de produits hautement actifs et cytotoxiques en France - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Myonex-logo.jpg\",\"datePublished\":\"2026-05-19T12:59:48+00:00\",\"dateModified\":\"2026-05-19T13:00:41+00:00\",\"description\":\"Myonex annonce l\u2019extension de ses capacit\u00e9s de conditionnement primaire avec l\u2019autorisation de r\u00e9aliser sur son site du Haillan, en France, des op\u00e9rations de conditionnement primaire sous BPF (Bonnes Pratiques de Fabrication) pour des produits pharmaceutiques hautement actifs et dangereux, incluant des compos\u00e9s cytotoxiques et hormonaux.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Myonex-logo.jpg\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Myonex-logo.jpg\",\"width\":1200,\"height\":627},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myonex triple ses capacit\u00e9s de conditionnement primaire de produits hautement actifs et cytotoxiques en France\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029\",\"name\":\"Maissa Pote\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g\",\"caption\":\"Maissa Pote\"},\"url\":\"https:\/\/mabdesign.fr\/en\/author\/communication\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myonex triple ses capacit\u00e9s de conditionnement primaire de produits hautement actifs et cytotoxiques en France - MabDesign","description":"Myonex annonce l\u2019extension de ses capacit\u00e9s de conditionnement primaire avec l\u2019autorisation de r\u00e9aliser sur son site du Haillan, en France, des op\u00e9rations de conditionnement primaire sous BPF (Bonnes Pratiques de Fabrication) pour des produits pharmaceutiques hautement actifs et dangereux, incluant des compos\u00e9s cytotoxiques et hormonaux.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/","og_locale":"en_US","og_type":"article","og_title":"Myonex triple ses capacit\u00e9s de conditionnement primaire de produits hautement actifs et cytotoxiques en France - MabDesign","og_description":"Myonex annonce l\u2019extension de ses capacit\u00e9s de conditionnement primaire avec l\u2019autorisation de r\u00e9aliser sur son site du Haillan, en France, des op\u00e9rations de conditionnement primaire sous BPF (Bonnes Pratiques de Fabrication) pour des produits pharmaceutiques hautement actifs et dangereux, incluant des compos\u00e9s cytotoxiques et hormonaux.","og_url":"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/","og_site_name":"MabDesign","article_published_time":"2026-05-19T12:59:48+00:00","article_modified_time":"2026-05-19T13:00:41+00:00","og_image":[{"width":1200,"height":627,"url":"http:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Myonex-logo.jpg","type":"image\/jpeg"}],"author":"Maissa Pote","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"Maissa Pote","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/"},"author":{"name":"Maissa Pote","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029"},"headline":"Myonex triple ses capacit\u00e9s de conditionnement primaire de produits hautement actifs et cytotoxiques en France","datePublished":"2026-05-19T12:59:48+00:00","dateModified":"2026-05-19T13:00:41+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/"},"wordCount":153,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Myonex-logo.jpg","articleSection":["News","Our members"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/","url":"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/","name":"Myonex triple ses capacit\u00e9s de conditionnement primaire de produits hautement actifs et cytotoxiques en France - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Myonex-logo.jpg","datePublished":"2026-05-19T12:59:48+00:00","dateModified":"2026-05-19T13:00:41+00:00","description":"Myonex annonce l\u2019extension de ses capacit\u00e9s de conditionnement primaire avec l\u2019autorisation de r\u00e9aliser sur son site du Haillan, en France, des op\u00e9rations de conditionnement primaire sous BPF (Bonnes Pratiques de Fabrication) pour des produits pharmaceutiques hautement actifs et dangereux, incluant des compos\u00e9s cytotoxiques et hormonaux.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Myonex-logo.jpg","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2026\/05\/Myonex-logo.jpg","width":1200,"height":627},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/myonex-triple-ses-capacites-de-conditionnement-primaire-de-produits-hautement-actifs-et-cytotoxiques-en-france\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Myonex triple ses capacit\u00e9s de conditionnement primaire de produits hautement actifs et cytotoxiques en France"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029","name":"Maissa Pote","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g","caption":"Maissa Pote"},"url":"https:\/\/mabdesign.fr\/en\/author\/communication\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/38472","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=38472"}],"version-history":[{"count":1,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/38472\/revisions"}],"predecessor-version":[{"id":38474,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/38472\/revisions\/38474"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/38469"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=38472"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=38472"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=38472"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}